Search
1 result for “Germany”
Politics• Jun 27
U.S. Launches Pharma Pricing Probe Against Germany
The U.S. Trade Representative has initiated a Section 301 investigation into Germany's pharmaceutical pricing practices, alleging underpayment for innovative drugs and a disproportionate shift of R&D costs to U.S. consumers.